UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon
|
2019-02-27 16:47
라인
Korea’s drug exports hit record high in 2018, industry group says
Won Hee-mok, president of the Korea Pharmaceutical and Bio-Pharma Manufactu...
by Kim Yun-mi
|
2019-02-27 13:08
라인
GC unveils P1 results for hepatitis B treatment
GC said Monday that it has presented the phase 1 clinical trial results for...
by Lee Han-soo
|
2019-02-26 16:07
라인
‘Heat-not-burn cigarettes as risky as traditional ones’
An expert pointed out how harmful so-called “heat-not-burn” cigarettes coul...
by Kim Yun-mi
|
2019-02-26 15:45
라인
Yuclid’s antiplatelet effect confirmed in patients undergoing carotid artery stenting
Local researchers said they confirmed the antiplatelet efficacy of Yuyu Pha...
by Lee Hye-seon
|
2019-02-26 14:36
라인
‘Hardy kiwi extract can treat psoriasis’
Viromed said Monday that it has scientifically identified ow PG102, a singl...
by Lee Han-soo
|
2019-02-26 14:34
라인
Daewon licenses in Tium Bio’s endometriosis drug candidate
Daewon Pharmaceutical said Tuesday that it has signed a licensing agreement...
by Lee Han-soo
|
2019-02-26 13:58
라인
CrystalGenomics’ US partner applies for P1 trial for leukemia treatment
CrystalGenomics said Tuesday that Aptose Bioscience, its U.S. partner, has ...
by Lee Han-soo
|
2019-02-26 11:29
라인
Regulator OKs GC’s P3 trial of BCG vaccine
GC said Monday that the Ministry of Food and Drug Safety has approved its p...
by Lee Han-soo
|
2019-02-25 14:07
라인
Lung cancer 2nd treatment Alunbrig likely to get insurance coverage
The National Health Insurance Service’s drug price assessment committee rec...
by Kim Yun-mi
|
2019-02-25 14:06
라인
Regulator OKs Bukwang’s anticancer treatment
Bukwang Pharmaceutical said Thursday that the Ministry of Food and Drug Saf...
by Lee Han-soo
|
2019-02-22 15:29
라인
Will first-ever treatment for nonalcoholic fatty liver arrive?
Pharmaceutical firms around the world are striving to become the world’s fi...
by Kim Yun-mi
|
2019-02-22 15:29
라인
Hugel hits record-high quarterly sales
Hugel said Friday it registered highest quarterly turnover in the final thr...
by Lee Han-soo
|
2019-02-22 13:30
라인
Huons posts record-high sales in 2018
Huons said Wednesday that it registered 328.6 billion won ($291.9 million) ...
by Lee Han-soo
|
2019-02-21 17:17
라인
Mediforum verifies safety, efficacy of dementia treatment candidate
Mediforum said Thursday it has verified the safety and efficacy of PM012, a...
by Lee Han-soo
|
2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, can i...
by Kim Yun-mi
|
2019-02-21 15:13
라인
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
Astellas Pharma Korea said it obtained regulatory approval for Xtandi (ingr...
by Kim Yun-mi
|
2019-02-21 15:10
라인
SCM, Allele to develop diabetes treatment
SCM Life Science said Thursday it has signed a joint research agreement wit...
by Lee Han-soo
|
2019-02-21 14:57
라인
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
SK Bioscience’s Skypheumo, a pneumococcal conjugate vaccine (PCV) approval,...
by Lee Han-soo
|
2019-02-20 16:18
라인
FDA rejects Medytox’s ‘citizen petition’ against Daewoong
Daewoong Pharmaceutical said Wednesday that the FDA rejected Medytox’s “cit...
by Lee Han-soo
|
2019-02-20 14:37
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top